Quetiapine with lithium or divalproex for the treatment of bipolar mania: A randomized, double-blind, placebo-controlled study

Bipolar Disorders

Volumn 6, Issue 3, 2004, Pages 213-223

  Sachs, Gary ^a   Chengappa, K N R ^b   Suppes, T ^c   Mullen, J A ^d   Brecher, M ^d   Devine, N A ^d   Sweitzer, D E ^d  

^a Harvard Bipolar Research Program   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

^d ASTRAZENECA   (United Kingdom)

Author keywords

Bipolar disorder; Combination therapy; Divalproex; Lithium; Mania; Quetiapine

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CHLORAL HYDRATE; CYTOCHROME P450 INHIBITOR; FLUPHENAZINE; HALOPERIDOL; LITHIUM; LORAZEPAM; PLACEBO; QUETIAPINE; THIORIDAZINE; VALPROATE SEMISODIUM; ZALEPLON; ZOLPIDEM;

ADULT; ARTICLE; ASTHENIA; BIPOLAR MANIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MONOTHERAPY; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; REMISSION; SCORING SYSTEM; SOMNOLENCE; STATISTICAL SIGNIFICANCE; XEROSTOMIA;

ADULT; ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DIBENZOTHIAZEPINES; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; LITHIUM CARBONATE; MALE; VALPROIC ACID;

EID: 2542562740     PISSN: 13985647     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2004.00115.x     Document Type: Article

References (32)

1. Woods SW. The economic burden of bipolar disease. J Clin Psychiatry 2000; 61 (Suppl. 13): 38-41.
2. Keck PE Jr, McElroy SL, Strakowski SM et al. 12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode. Am J Psychiatry 1998; 155: 646-652.
3. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 2002; 159: 1-50.
4. Suppes T, Dennehy EB, Swann AC. Report of the Texas Consensus Conference Panel on Medication Treatment of Bipolar Disorder 2000. J Clin Psychiatry 2002; 63: 288-299.
5. Young AH, Macritchie KA, Calabrese JR. Treatment of bipolar affective disorder. BMJ 2000; 321: 1302-1303.
6. Suppes T, Rush AJ Jr, Kraemer HC, Webb A. Treatment algorithm use to optimize management of symptomatic patients with a history of mania. J Clin Psychiatry 1998; 59: 89-96; quiz 97-98.
7. Ghaemi S, Goldberg J, Ko J, McNally E. Quetiapine treatment of rapid-cycling bipolar disorder: an open prospective study. Int J Neuropsychopharmacol 2002; 5 (Suppl. 1): S110.
8. Dunayevich E, Tugrul RN, Strakowski SM. Quetiapine in the treatment of mania. Poster presented at the 7th World Congress of Biological Psychiatry, July 2001, Berlin, Germany.
9. Zarate CA Jr, Rothschild A, Fletcher KE, Madrid A, Zapatel J. Clinical predictors of acute response with quetiapine in psychotic mood disorders. J Clin Psychiatry 2000; 61: 185-189.
10. Chisholm K, Dennehy E, Suppes T. Clinical response to quetiapine add-on for treatment of refractory bipolar disorder. Paper presented at 2nd International Forum on Mood and Anxiety Disorders; November 28-December 1, 2001, Monte Carlo, Monaco.
11. Sajatovic M, Brescan DW, Perez DE et al. Quetiapine alone and added to a mood stabilizer for serious mood disorders. J Clin Psychiatry 2001; 62: 728-732.
12. DelBello MP, Schwiers ML, Rosenberg HL, Strakowski SM. A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J Am Acad Child Adolesc Psychiatry 2002; 41: 1216-1223.
13. Sachs GS, Grossman F, Ghaemi SN, Okamoto A, Bowden CL. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Am J Psychiatry 2002; 159: 1146-1154.
14. Tohen M, Baker RW, Altshuler LL et al. Olanzapine versus divalproex in the treatment of acute mania. Am J Psychiatry 2002; 159: 1011-1017.
15. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429-435.
16. Tohen M, Jacobs TG, Grundy SL et al. Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzapine HGGW Study Group. Arch Gen Psychiatry 2000; 57: 841-849.
17. Spearing MK, Post RM, Leverich GS, Brandt D, Nolen W. Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res 1997; 73: 159-171.
18. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382-389.
19. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987; 13: 261-276.
20. White L, Harvey PD, Opler L, Lindenmayer JP. Empirical assessment of the factorial structure of clinical symptoms in schizophrenia. A multisite, multimodel evaluation of the factorial structure of the Positive and Negative Syndrome Scale. The PANSS Study Group. Psychopathology 1997; 30: 263-274.
21. Endicott J, Spitzer RL, Fleiss JL, Cohen J. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 1976; 33: 766-771.
22. Simpson GM. Angus JW. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 1970; 212: 11-19.
23. Barnes TR. A rating scale for drug-induced akathisia. Br J Psychiatry 1989; 154: 672-676.
24. Montgomery DB. ECNP Consensus Meeting March 2000 Nice: guidelines for investigating efficacy in bipolar disorder. European College of Neuropsychopharmacology. Eur Neuropsychopharmacol 2001; 11: 79-88.
25. Vieta E, Parramon G, Padrell E et al. Quetiapine in the treatment of rapid cycling bipolar disorder. Bipolar Disord 2002; 4: 335-340.
26. Ghaemi SN, Rosenquist K, Ko J, Goodwin FK, Baldessarini RJ. Effects of newer and older antidepressants in bipolar depression (abstract). Bipolar Disord 2003; 5 (Suppl. 1): 49.
27. Chengappa KN, Goldstein JM, Greenwood M, John V, Levine J. A post hoc analysis of the impact on hostility and agitation of quetiapine and haloperidol among patients with schizophrenia. Clin Ther 2003; 25: 530-541.
28. Arvanitis LA, Miller BG. Multiple fixed doses of 'Seroquel' (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group. Biol Psychiatry 1997; 42: 233-246.
29. Copolov DL, Link CG, Kowalcyk B. A multicentre, double-blind, randomized comparison of quetiapine (ICI 204,636, 'Seroquel') and haloperidol in schizophrenia. Psychol Med 2000; 30: 95-105.
30. Small JG, Hirsch SR, Arvanitis LA, Miller BG, Link CG. Quetiapine in patients with schizophrenia. A high- and low-dose double-blind comparison with placebo. Seroquel Study Group. Arch Gen Psychiatry 1997; 54: 549-557.
31. Paulsson B, Huizar K. Quetiapine monotherapy versus placebo for acute bipolar mania (STAMP 2) (abstract). Bipolar Disord 2003; 5: 74.
32. Bowden CL, Brugger AM, Swann AC et al. Efficacy of divalproex versus lithium and placebo in the treatment of mania. The Depakote Mania Study Group. JAMA 1994; 271: 918-924.